FDA panel says Karyopharm's cancer drug shows 'significant toxicity' - Boston Business Journal https://t.co/3lCUOQO51W — IDRO (@IDROOhio) February 26, 2019
FDA panel says Karyopharm's cancer drug shows 'significant toxicity' - Boston Business Journal https://t.co/3lCUOQO51W
No comments:
Post a Comment